https://www.selleckchem.com/pr....oducts/pkm2-inhibito
Knockdown of BUB1B also suppressed the expression of CD44 and increased the expression of phospho-p53 (Ser15). In silico analysis showed that BUB1B was associated with inflamed CD8+, exhausted T-cell signature, IFN-γ signature, and the response to nivolumab. These results suggest that BUB1B plays an oncogenic role and may be a promising predictive biomarker for survival in RCC. These results suggest that BUB1B plays an oncogenic role and may be a promising predictive biomarker for survival in RCC. Hair cycle is regula
Like
Comment
Share
